Select Transactions
Filter by
Transaction Type
Sector of Focus
June 2020
Minority equity investment by Perrigo
Exclusive financial advisor
$50,000,000
September 2019
Minority equity investment led by Flexpoint Ford
Exclusive financial advisor
July 2019
Series C financing led by Updata Partners
Exclusive financial advisor
$22,000,000
March 2019
Follow-on
Co-manager
$397,000,000
March 2019
Has been sold to Tabula Rasa Healthcare
Exclusive financial advisor
$150,000,000
March 2019
Follow-on
Co-manager
$275,000,000
January 2019
Follow-on
Co-manager
$105,000,000
January 2019
Has been sold to Cardinal Health
Exclusive financial advisor
August 2018
Minority growth equity investment by Primus
Exclusive financial advisor
$60,000,000
August 2018
Follow-on
Co-manager
$143,692,500
July 2018
Convertible debt
Financial advisor
$200,000,000
June 2018
IPO
Co-manager
$88,200,000
June 2018
Growth equity investment by Mainsail Partners
Exclusive financial advisor
$60,000,000
May 2018
IPO
Co-manager
$310,500,000
January 2018
Has been sold to Daxko
Exclusive financial advisor
January 2018
Convertible senior note
Co-manager
$200,000,000
December 2017
Follow-on
Co-manager
$82,500,000
September 2017
Follow-on
Co-manager
$179,000,000
July 2017
Preferred stock growth investment by Bison Capital
Exclusive placement agent
May 2017
Follow-on
Co-manager
$346,500,000
March 2017
Senior secured notes
Financial advisor
$250,000,000
December 2016
Senior secured notes
Co-manager
$130,000,000
November 2016
Has acquired GPS Heroes
Exclusive financial advisor
October 2016
IPO
Co-manager
$346,500,000
September 2016
Series B convertible preferred stock by Primus
Exclusive placement agent
June 2016
IPO
Co-manager
$91,000,000
May 2016
Series D preferred stock by SSM Partners
Exclusive placement agent
$19,250,000
February 2016
Growth investment by Bison Capital
Exclusive placement agent
December 2015
Has been sold to Daxko
Exclusive financial advisor
September 2015
Follow-on
Co-manager
$105,400,000
September 2015
Follow-on
Co-manager
$119,000,000
June 2015
Convertible senior note
Co-manager
$230,000,000
May 2015
Convertible senior note
Co-manager
$150,000,000
May 2015
Follow-on
Co-manager
$87,000,000
May 2015
Has been sold to ProPharma Group
Exclusive financial advisor
May 2015
Convertible senior note
Financial advisor
$150,000,000
November 2014
Growth investment by Francisco Partners
Exclusive financial advisor
June 2014
Series D preferred stock
Exclusive financial advisor
April 2014
Series C preferred stock growth investment by Bain Capital
Exclusive placement agent
$13,500,000
January 2014
Has been sold to ServiceSource
Exclusive financial advisor
$32,500,000
December 2013
Convertible senior note
Co-manager
$175,000,000
November 2013
Follow-on
Joint book running manager
$22,500,000
November 2013
Registered direct
Co-placement agent
$20,000,000
November 2013
Follow-on
Co-manager
$188,700,000
November 2013
Follow-on
Co-manager
$47,000,000
February 2013
Follow-on
Co-manager
$48,000,000
January 2013
PIPE
Co-lead placement agent
$11,000,000
January 2013
Has been sold to Ascensus
Financial co-advisor
October 2012
Follow-on
Co-manager
$20,000,000
September 2012
IPO
Co-manager
$91,000,000
August 2012
PIPE
Exclusive placement agent
$12,000,000
August 2012
has sold its business and technology assets
Exclusive financial advisor
April 2012
IPO
Co-manager
$33,300,000
April 2012
IPO
Co-manager
$82,300,000
March 2012
PIPE
Exclusive placement agent
$7,200,000
March 2012
IPO
Co-manager
$88,000,000
March 2012
PIPE
Co-placement agent
$9,000,000
January 2012
Has acquired Environmental Systems Products
Exclusive financial advisor
$9,700,000
December 2011
Has acquired FAS Controls Inc.
Exclusive financial advisor
December 2011
IPO
Co-manager
$88,000,000
December 2011
Series B preferred stock
Exclusive placement agent and financial advisor
$2,050,000
September 2011
Series C preferred stock
Exclusive financial advisor
$21,000,000
September 2011
Has acquired Integrated Revenue Management
Exclusive financial advisor
March 2011
Has been sold to Falck Holdings A/S
Financial advisor
January 2011
Registered direct
Co-lead placement agent
$13,100,000
October 2010
Raised capital from Abraxis BioScience
Financial advisor
Investment banking and corporate finance services are offered through First Analysis Securities Corporation ("FASC" or "First Analysis Securities"), a subsidiary of First Analysis Corp.
©2020 by First Analysis Corporation.
One South Wacker Drive
  ·  
Suite 3900
  ·  
Chicago, IL 60606
  ·  
312-258-1400
First Analysis Securities Corp. (FASC) is a registered broker/dealer with FINRA and member SIPC.